AbbVie Inc. (BCBA:ABBV)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of ARS 579.57 trillion. The enterprise value is 674.19 trillion.

Market Cap	579.57T
Enterprise Value	674.19T

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.76B

Valuation Ratios

The trailing PE ratio is 130.63 and the forward PE ratio is 16.93.

PE Ratio	130.63
Forward PE	16.93
PS Ratio	8.34
PB Ratio	-3,524.17
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.09, with an EV/FCF ratio of 31.02.

EV / Earnings	151.96
EV / Sales	7.84
EV / EBITDA	16.09
EV / EBIT	23.08
EV / FCF	31.02

Financial Position

The company has a current ratio of 0.74

Current Ratio	0.74
Quick Ratio	0.48
Debt / Equity	n/a
Debt / EBITDA	2.48
Debt / FCF	3.87
Interest Coverage	6.92

Financial Efficiency

Return on equity (ROE) is 112.85% and return on invested capital (ROIC) is 16.70%.

Return on Equity (ROE)	112.85%
Return on Assets (ROA)	8.87%
Return on Invested Capital (ROIC)	16.70%
Return on Capital Employed (ROCE)	20.33%
Revenue Per Employee	1.26B
Profits Per Employee	80.67M
Employee Count	55,000
Asset Turnover	0.42
Inventory Turnover	3.65

Taxes

Income Tax	-883.05B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+46.54%
50-Day Moving Average	27,481.70
200-Day Moving Average	23,687.80
Relative Strength Index (RSI)	87.95
Average Volume (20 Days)	884

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.72

Income Statement

In the last 12 months, AbbVie had revenue of ARS 69.51 trillion and earned 4.44 trillion in profits. Earnings per share was 2,502.76.

Revenue	69.51T
Gross Profit	49.52T
Operating Income	23.60T
Pretax Income	3.61T
Net Income	4.44T
EBITDA	33.46T
EBIT	23.60T
Earnings Per Share (EPS)	2,502.76

Balance Sheet

The company has 7.71 trillion in cash and 84.12 trillion in debt, giving a net cash position of -76,409.42 billion.

Cash & Cash Equivalents	7.71T
Total Debt	84.12T
Net Cash	-76,409.42B
Net Cash Per Share	n/a
Equity (Book Value)	-164.45B
Book Value Per Share	-123.46
Working Capital	-12,520.00B

Cash Flow

In the last 12 months, operating cash flow was 22.98 trillion and capital expenditures -1,244.13 billion, giving a free cash flow of 21.74 trillion.

Operating Cash Flow	22.98T
Capital Expenditures	-1,244.13B
Free Cash Flow	21.74T
FCF Per Share	n/a

Margins

Gross margin is 71.25%, with operating and profit margins of 33.95% and 6.45%.

Gross Margin	71.25%
Operating Margin	33.95%
Pretax Margin	5.19%
Profit Margin	6.45%
EBITDA Margin	48.13%
EBIT Margin	33.95%
FCF Margin	31.27%

Dividends & Yields

AbbVie does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	301.30%
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	0.77%
FCF Yield	3.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	6